For Investors
King Pharmaceuticals, Inc., headquartered in Bristol, Tennessee, focuses on the development and promotion of novel branded pharmaceutical products and technologies that complement the company’s focus in specialty driven markets, particularly neuroscience, hospital and acute care. King is an established leading specialty pharmaceutical company, with a vision of bringing innovative, clinically-differentiated pharmaceutical products and technologies to market. The Company’s common stock trades on the New York Stock Exchange under the symbol “KG,” and is a component of the S&P 500 Index and the AMEX pharmaceutical index.
